Patent details

EP3183252 Title: OXALATE SALT OF RUXOLITINIB

Basic Information

Publication number:
EP3183252
PCT Application Number:
EP2015069296
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP157533746
PCT Publication Number:
WO2016026974
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
OXALATE SALT OF RUXOLITINIB
French Title of Invention:
SEL D'OXALATE DE RUXOLITINIB
German Title of Invention:
OXALATSALZ NACH RUXOLITINIB
SPC Number:

Dates

Filing date:
21/08/2015
Grant date:
12/05/2021
EP Publication Date:
28/06/2017
PCT Publication Date:
25/02/2016
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
12/05/2021
EP B1 Publication Date:
12/05/2021
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
21/08/2021
Expiration date:
21/08/2035
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
05/05/2021
 
 

Name:
ratiopharm GmbH
Address:
Graf-Arco-Strasse 3, 89079 Ulm, Germany (DE)

Inventor

1

Name:
SELIG, Roland
Address:
Germany (DE)

2

Name:
ALBRECHT, Wolfgang
Address:
Germany (DE)

Priority

Priority Number:
14181843
Priority Date:
21/08/2014
Priority Country:
European Patent Office (EPO) (EP)

Classification

IPC classification:
C07D 487/04;

Publication

European Patent Bulletin

Issue number:
202119
Publication date:
12/05/2021
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages